Constructing Tumor Progression Pathways and Biomarker Discovery with Fuzzy Kernel Kmeans and DNA Methylation Data

被引:0
|
作者
Liu, Zhenqiu [1 ]
Guo, Zhongmin [2 ]
Tan, Ming [1 ]
机构
[1] Univ Maryland, Greenebaum Canc Ctr, Div Biostat, 22 South Greene St, Baltimore, MD 21201 USA
[2] Univ Maryland, Greenebaum Canc Ctr, Mol & Struct Biol, Baltimore, MD 21201 USA
来源
CANCER INFORMATICS | 2008年 / 6卷
关键词
progression pathway; kernel kmeans; fuzzy kernel kmeans; biomarkers;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Constructing pathways of tumor progression and discovering the biomarkers associated with cancer is critical for understanding the molecular basis of the disease and for the establishment of novel chemotherapeutic approaches and in turn improving the clinical efficiency of the drugs. It has recently received a lot of attention from bioinformatics researchers. However, relatively few methods are available for constructing pathways. This article develops a novel entropy kernel based kernel clustering and fuzzy kernel clustering algorithms to construct the tumor progression pathways using CpG island methylation data. The methylation data which come from tumor tissues diagnosed at different stages can be used to distinguish epigenotype and phenotypes the describe the molecular events of different phases. Using kernel and fuzzy kernel kmeans, we built tumor progression trees to describe the pathways of tumor progression and find the possible biomarkers associated with cancer. Our results indicate that the proposed algorithms together with methylation profiles can predict the tumor progression stages and discover the biomarkers efficiently. Software is available upon request.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 50 条
  • [41] DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage
    George S Watts
    Bernard W Futscher
    Nicholas Holtan
    Koen DeGeest
    Frederick E Domann
    Stephen L Rose
    BMC Medical Genomics, 1
  • [42] DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage
    Watts, George S.
    Futscher, Bernard W.
    Holtan, Nicholas
    DeGeest, Koen
    Domann, Frederick E.
    Rose, Stephen L.
    BMC MEDICAL GENOMICS, 2008, 1 (1)
  • [43] Genome-Wide Profiling of DNA Methylation and Tumor Progression in Human Hepatocellular Carcinoma
    Nishida, Naoshi
    Nishimura, Takafumi
    Nakai, Takuya
    Chishina, Hirokazu
    Arizumi, Tadaaki
    Takita, Masahiro
    Kitai, Satoshi
    Yada, Norihisa
    Hagiwara, Satoru
    Inoue, Tatsuo
    Minami, Yasunori
    Ueshima, Kazuomi
    Sakurai, Toshiharu
    Kudo, Masatoshi
    DIGESTIVE DISEASES, 2014, 32 (06) : 658 - 663
  • [44] Deconvolution of tumor composition using partially available DNA methylation data
    Dingqin He
    Ming Chen
    Wenjuan Wang
    Chunhui Song
    Yufang Qin
    BMC Bioinformatics, 23
  • [45] Deconvolution of tumor composition using partially available DNA methylation data
    He, Dingqin
    Chen, Ming
    Wang, Wenjuan
    Song, Chunhui
    Qin, Yufang
    BMC BIOINFORMATICS, 2022, 23 (01)
  • [46] Developing a biomarker for restless leg syndrome using genome wide DNA methylation data
    Roy, Arunima
    Earley, Christopher J.
    Allen, Richard P.
    Kaminsky, Zachary A.
    SLEEP MEDICINE, 2021, 78 : 120 - 127
  • [47] Genome-wide methylation analysis of circulating tumor DNA: A new biomarker for recurrent glioblastom
    Dai, Lin
    Liu, Zhihui
    Zhu, Yi
    Ma, Lixin
    HELIYON, 2023, 9 (03)
  • [48] Novel region discovery method for Infinium 450K DNA methylation data reveals changes associated with aging in muscle and neuronal pathways
    Ong, Mei-Lyn
    Holbrook, Joanna Dawn
    AGING CELL, 2014, 13 (01) : 142 - 155
  • [49] Development and validation of a novel EHR-based tumor progression outcome to support biomarker discovery.
    Kehl, Kenneth L.
    Hassett, Michael J.
    Stafford, Katherine A.
    Xu, Wenxin
    Johnson, Bruce E.
    Schrag, Deborah
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [50] Aberrant DNA methylation as a key modulator of cell death pathways: insights into cancer progression and other diseases
    Zahoor, Ambreen
    Khazer, Rafia
    Mehraj, Insha
    Gani, Ubaid
    Fayaz, Falah
    Khanday, Firdous A.
    Bhat, Sahar Saleem
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2025, 25 (01)